
News|Podcasts|September 6, 2024
Beyond the Birthrate: The Societal Costs of Maternal Mortality
Author(s)Miranda Schmalfuhs
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Advertisement
Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:
- The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study
- The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make
- Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health
- How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges
- and more!
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
2
From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI
3
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
4
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
5

